Delivra Health Brands Inc. announced a non-brokered private placement of up to 60,000,000 units at a price of CAD 0.015 per unit for the gross proceeds of CAD 900,000 on December 1, 2023. Each unit is comprised of one common share of the company and one common share purchase warrant. Each warrant will entitle the holder thereof to acquire one common share at a price of CAD 0.05 per warrant share for 36 months following the completion of the offering.

All securities issued pursuant to the offering are subject to a hold period of four months plus a day from the date of issuance. The company may pay certain finders a cash finder's fee of up to 7%. Completion of the offering is subject to, among other things, acceptance by the Exchange.

The transaction is expected to close on or about December 8, 2023. Certain insiders of the company will be participating in the offering.